Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis

Cornea

Volumn 15, Issue 5, 1996, Pages 533-536

  Michalová, Kira ^a   Moyes, Andrew L ^a   Cameron, Sarah ^a   Juni, Billie Anne ^a   Obritsch, Wesley F ^a   Dvorak, John A ^a   Doughman, Donald J ^a,b   Rhame, Frank S ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Keratitis; Povidone iodine; Pseudomonas aeruginosa

Indexed keywords

POVIDONE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; CONTROLLED STUDY; CORNEA ULCER; DRUG EFFICACY; EXCISION; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; STATISTICAL ANALYSIS; TOPICAL DRUG ADMINISTRATION;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; COLONY COUNT, MICROBIAL; CORNEA; CORNEAL ULCER; DISEASE MODELS, ANIMAL; EYE INFECTIONS, BACTERIAL; OPHTHALMIC SOLUTIONS; POVIDONE-IODINE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS;

EID: 0029758807     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hale LM. The treatment of corneal ulcer with povidone-iodine (Betadine). N C Med J 1969;30:54-6.
2. Kadam SP. Application of Betadine (povidone-iodine) to infected corneal ulcer. Ind J Ophthalmol 1987;35:135-6.
3. Siggia S. The chemistry of polyvinylpyrrolidone-iodine. J Am Pharm Assoc 1957;46:201-3.
4. Shelanski A, Shelanski V. PVP-Iodine: history, toxicity and therapeutic uses. J Int Coll Surg 1956;25:727-34.
5. Material provided by Escalon Ophthalmics, Inc. and Purdue Frederick Company, 1992.
6. York KK, Miller S. Gaster RN, Burstein NL. Polyvinylpyrrolidone iodine: corneal toxicology and epithelial healing in a rabbit model. J Ocul Pharmacol 1988;4:351-7.
7. Apt L, Isenberg S, Yoshimorie R. Chemical preparation of the eye in ophthalmic surgery, II: effect of povidone-iodine on the conjunctiva. Arch Ophthalmol 1984;102:728-9.
8. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-75.
9. Hyndiuk RA. Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc 1981;79:541-624.
10. Silbinger J, Stern GA. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis. Ophthalmology 1992;99:889-92.
11. Gritz DC, McDonnell PJ, Lee TY, Tang-Liu D, Hubbard BB, Gwon A. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. Cornea 1992;11: 143-7.
12. Hobden JA, O'Callaghan RJ, Hill JM, Hagenah M, Insler MS, Reidy JJ. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis. Curr Eye Res 1992;11: 259-65.
13. Schuhman G, Vidic B. Clinical experience with povidone-iodine drops in patients with conjunctivitis and keratoconjunctivitis. J Hosp Infect 1985;6(suppl):173-5.
14. Reller LB, Schoenknecht FD, Kenny MA, Sheriss JC. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in the media. J Infect Dis 1974;130:454-63.
15. Laibson PR. Cornea and sciera. Arch Ophthalmol 1972;88: 553-74.
16. Favero MS, Bond WW, Peterson MJ, Cook EH Jr. Scanning electron microscopic observations of bacteria resistant to iodophor solutions. In: Digenis GA, Ansel J, eds. Proceedings of the International Symposium on Povidone. Lexington: University of Kentucky College of Pharmacology, 1983.